Industry Focus

Here's why  Exelixis, Pacira Pharmaceuticals, Kite Pharma, Exact Sciences, and Portola Pharmaceuticals are up more than 50% in the first two months of 2017. 

Direct download: 20170308_IF_Healthcare.mp3
Category:Podcast -- posted at: 3:30pm EDT

1